FAP and FAPI-PET/CT in malignant and non-malignant diseases: a perfect symbiosis?

A fibroblast activation protein (FAP) is an atypical type II transmembrane serine protease with both endopeptidase and post-proline dipeptidyl peptidase activity. FAP is overexpressed in cancer-associated fibroblasts (CAFs), which are found in most epithelial tumors. CAFs have been implicated in pro...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Dendl, Katharina (VerfasserIn) , Körber, Stefan A. (VerfasserIn) , Kratochwil, Clemens (VerfasserIn) , Cardinale, Jens (VerfasserIn) , Finck, Rebecca (VerfasserIn) , Dabir, Mardjan (VerfasserIn) , Novruzov, Emil (VerfasserIn) , Watabe, Tadashi (VerfasserIn) , Kramer, Vasko (VerfasserIn) , Choyke, Peter L. (VerfasserIn) , Haberkorn, Uwe (VerfasserIn) , Giesel, Frederik L. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 30 September 2021
In: Cancers
Year: 2021, Jahrgang: 13, Heft: 19, Pages: 1-17
ISSN:2072-6694
DOI:10.3390/cancers13194946
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3390/cancers13194946
Verlag, lizenzpflichtig, Volltext: https://www.mdpi.com/2072-6694/13/19/4946
Volltext
Verfasserangaben:Katharina Dendl, Stefan A. Koerber, Clemens Kratochwil, Jens Cardinale, Rebecca Finck, Mardjan Dabir, Emil Novruzov, Tadashi Watabe, Vasko Kramer, Peter L. Choyke, Uwe Haberkorn and Frederik L. Giesel

MARC

LEADER 00000caa a2200000 c 4500
001 1786951150
003 DE-627
005 20230428185132.0
007 cr uuu---uuuuu
008 220122s2021 xx |||||o 00| ||eng c
024 7 |a 10.3390/cancers13194946  |2 doi 
035 |a (DE-627)1786951150 
035 |a (DE-599)KXP1786951150 
035 |a (OCoLC)1341439095 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Dendl, Katharina  |d 1997-  |e VerfasserIn  |0 (DE-588)1249861136  |0 (DE-627)1786465574  |4 aut 
245 1 0 |a FAP and FAPI-PET/CT in malignant and non-malignant diseases  |b a perfect symbiosis?  |c Katharina Dendl, Stefan A. Koerber, Clemens Kratochwil, Jens Cardinale, Rebecca Finck, Mardjan Dabir, Emil Novruzov, Tadashi Watabe, Vasko Kramer, Peter L. Choyke, Uwe Haberkorn and Frederik L. Giesel 
264 1 |c 30 September 2021 
300 |a 17 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 22.01.2022 
520 |a A fibroblast activation protein (FAP) is an atypical type II transmembrane serine protease with both endopeptidase and post-proline dipeptidyl peptidase activity. FAP is overexpressed in cancer-associated fibroblasts (CAFs), which are found in most epithelial tumors. CAFs have been implicated in promoting tumor cell invasion, angiogenesis and growth and their presence correlates with a poor prognosis. However, FAP can generally be found during the remodeling of the extracellular matrix and therefore can be detected in wound healing and benign diseases. For instance, chronic inflammation, arthritis, fibrosis and ischemic heart tissue after a myocardial infarction are FAP-positive diseases. Therefore, quinoline-based FAP inhibitors (FAPIs) bind with a high affinity not only to tumors but also to a variety of benign pathologic processes. When these inhibitors are radiolabeled with positron emitting radioisotopes, they provide new diagnostic and prognostic tools as well as insights into the role of the microenvironment in a disease. In this respect, they deliver additional information beyond what is afforded by conventional FDG PET scans that typically report on glucose uptake. Thus, FAP ligands are considered to be highly promising novel tracers that offer a new diagnostic and theranostic potential in a variety of diseases. 
650 4 |a benign diseases 
650 4 |a CAFs 
650 4 |a FAP 
650 4 |a FAPI-PET/CT 
650 4 |a fibroblast 
650 4 |a various malignancies 
700 1 |a Körber, Stefan A.  |e VerfasserIn  |0 (DE-588)1023031140  |0 (DE-627)717350053  |0 (DE-576)366291823  |4 aut 
700 1 |a Kratochwil, Clemens  |d 1978-  |e VerfasserIn  |0 (DE-588)134026276  |0 (DE-627)559871686  |0 (DE-576)300262787  |4 aut 
700 1 |a Cardinale, Jens  |d 1981-  |e VerfasserIn  |0 (DE-588)1030356505  |0 (DE-627)735121206  |0 (DE-576)378165941  |4 aut 
700 1 |a Finck, Rebecca  |d 1990-  |e VerfasserIn  |0 (DE-588)1279223588  |0 (DE-627)1832500284  |4 aut 
700 1 |a Dabir, Mardjan  |e VerfasserIn  |4 aut 
700 1 |a Novruzov, Emil  |e VerfasserIn  |4 aut 
700 1 |a Watabe, Tadashi  |e VerfasserIn  |4 aut 
700 1 |a Kramer, Vasko  |e VerfasserIn  |4 aut 
700 1 |a Choyke, Peter L.  |e VerfasserIn  |4 aut 
700 1 |a Haberkorn, Uwe  |d 1959-  |e VerfasserIn  |0 (DE-588)1022913905  |0 (DE-627)717331245  |0 (DE-576)366166352  |4 aut 
700 1 |a Giesel, Frederik L.  |d 1970-  |e VerfasserIn  |0 (DE-588)129031240  |0 (DE-627)387883878  |0 (DE-576)297457071  |4 aut 
773 0 8 |i Enthalten in  |t Cancers  |d Basel : MDPI, 2009  |g 13(2021), 19, Artikel-ID 4946, Seite 1-17  |h Online-Ressource  |w (DE-627)614095670  |w (DE-600)2527080-1  |w (DE-576)313958548  |x 2072-6694  |7 nnas  |a FAP and FAPI-PET/CT in malignant and non-malignant diseases a perfect symbiosis? 
773 1 8 |g volume:13  |g year:2021  |g number:19  |g elocationid:4946  |g pages:1-17  |g extent:17  |a FAP and FAPI-PET/CT in malignant and non-malignant diseases a perfect symbiosis? 
856 4 0 |u https://doi.org/10.3390/cancers13194946  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.mdpi.com/2072-6694/13/19/4946  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20220122 
993 |a Article 
994 |a 2021 
998 |g 129031240  |a Giesel, Frederik L.  |m 129031240:Giesel, Frederik L.  |d 910000  |d 911400  |d 50000  |e 910000PG129031240  |e 911400PG129031240  |e 50000PG129031240  |k 0/910000/  |k 1/910000/911400/  |k 0/50000/  |p 12  |y j 
998 |g 1022913905  |a Haberkorn, Uwe  |m 1022913905:Haberkorn, Uwe  |d 910000  |d 911400  |e 910000PH1022913905  |e 911400PH1022913905  |k 0/910000/  |k 1/910000/911400/  |p 11 
998 |g 1279223588  |a Finck, Rebecca  |m 1279223588:Finck, Rebecca  |d 50000  |e 50000PF1279223588  |k 0/50000/  |p 5 
998 |g 1030356505  |a Cardinale, Jens  |m 1030356505:Cardinale, Jens  |d 910000  |d 911400  |e 910000PC1030356505  |e 911400PC1030356505  |k 0/910000/  |k 1/910000/911400/  |p 4 
998 |g 134026276  |a Kratochwil, Clemens  |m 134026276:Kratochwil, Clemens  |d 910000  |d 911400  |e 910000PK134026276  |e 911400PK134026276  |k 0/910000/  |k 1/910000/911400/  |p 3 
998 |g 1023031140  |a Körber, Stefan A.  |m 1023031140:Körber, Stefan A.  |d 910000  |d 911400  |d 50000  |e 910000PK1023031140  |e 911400PK1023031140  |e 50000PK1023031140  |k 0/910000/  |k 1/910000/911400/  |k 0/50000/  |p 2 
998 |g 1249861136  |a Dendl, Katharina  |m 1249861136:Dendl, Katharina  |d 50000  |e 50000PD1249861136  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN1786951150  |e 4041748909 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"display":"Dendl, Katharina","given":"Katharina","family":"Dendl","role":"aut"},{"display":"Körber, Stefan A.","given":"Stefan A.","family":"Körber","role":"aut"},{"family":"Kratochwil","given":"Clemens","display":"Kratochwil, Clemens","role":"aut"},{"role":"aut","display":"Cardinale, Jens","family":"Cardinale","given":"Jens"},{"role":"aut","display":"Finck, Rebecca","family":"Finck","given":"Rebecca"},{"role":"aut","given":"Mardjan","family":"Dabir","display":"Dabir, Mardjan"},{"display":"Novruzov, Emil","given":"Emil","family":"Novruzov","role":"aut"},{"display":"Watabe, Tadashi","family":"Watabe","given":"Tadashi","role":"aut"},{"display":"Kramer, Vasko","given":"Vasko","family":"Kramer","role":"aut"},{"given":"Peter L.","family":"Choyke","display":"Choyke, Peter L.","role":"aut"},{"family":"Haberkorn","given":"Uwe","display":"Haberkorn, Uwe","role":"aut"},{"given":"Frederik L.","family":"Giesel","display":"Giesel, Frederik L.","role":"aut"}],"title":[{"title":"FAP and FAPI-PET/CT in malignant and non-malignant diseases","subtitle":"a perfect symbiosis?","title_sort":"FAP and FAPI-PET/CT in malignant and non-malignant diseases"}],"origin":[{"dateIssuedDisp":"30 September 2021","dateIssuedKey":"2021"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 22.01.2022"],"recId":"1786951150","id":{"doi":["10.3390/cancers13194946"],"eki":["1786951150"]},"relHost":[{"disp":"FAP and FAPI-PET/CT in malignant and non-malignant diseases a perfect symbiosis?Cancers","physDesc":[{"extent":"Online-Ressource"}],"part":{"text":"13(2021), 19, Artikel-ID 4946, Seite 1-17","year":"2021","issue":"19","extent":"17","volume":"13","pages":"1-17"},"language":["eng"],"id":{"eki":["614095670"],"zdb":["2527080-1"],"issn":["2072-6694"]},"recId":"614095670","name":{"displayForm":["Molecular Diversity Preservation International (MDPI)"]},"note":["Gesehen am 27.05.2020"],"title":[{"title":"Cancers","title_sort":"Cancers"}],"pubHistory":["1.2009 -"],"type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"publisher":"MDPI","dateIssuedDisp":"2009-","publisherPlace":"Basel","dateIssuedKey":"2009"}]}],"name":{"displayForm":["Katharina Dendl, Stefan A. Koerber, Clemens Kratochwil, Jens Cardinale, Rebecca Finck, Mardjan Dabir, Emil Novruzov, Tadashi Watabe, Vasko Kramer, Peter L. Choyke, Uwe Haberkorn and Frederik L. Giesel"]},"physDesc":[{"extent":"17 S."}],"language":["eng"]} 
SRT |a DENDLKATHAFAPANDFAPI3020